Company intelligence / Profile preview

Kay Biotech

New Delhi, Delhi, India

Ownership: Private
Development stage: Other

Overview

Kay Biotech is an active Indian pharmaceutical company manufacturing and marketing branded and generic medicines, nutraceuticals, anti-infectives, HIV drugs, pain relief drugs, tablets, syrups, and supplements for a wide range of therapeutic areas. The company does not publicly report clinical trial results, as it primarily manufactures and distributes approved (generic and branded) drugs.[5][3][4]

Therapeutic areas: Infectious DiseasesMetabolic DisordersNeurology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Kay Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kay Biotech.

Explore the full profile